Figure 1
From: Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis
Flow chart of the study population. Among a total of 370 admitted patients with decompensated cirrhosis who were initially assessed for the inclusion, 259 patients were excluded due to unknown or abnormal baseline renal function, development of AKI at the time of admission, taking immunosuppressive drugs from previous transplantation or refusal to give consent etc. and 111 patients were finally enrolled.
